SG to launch national strategy for allied health professionals

It will also implement a mandatory continuing professional education by 2026.

Singapore is set to launch a national strategy for allied health professionals (AHPs), with full details expected in 2025.

A key focus of the strategy includes leadership development and the adoption of innovative technologies. For example, robotic process automation has already been utilised at Singapore General Hospital to improve patient care, showcasing the type of advancements the strategy aims to encourage.

Additionally, the plan will strengthen educational frameworks by implementing mandatory continuing professional education by 2026. This initiative is intended to ensure that AHPs maintain current skills and knowledge, building on efforts such as the integration of Entrustable Professional Activities in training programs to boost practical competencies.

Masagos Zulkifli, minister for Social and Family Development and second minister for Health, said this strategy is designed to enhance the role of the sector in addressing the evolving healthcare landscape and ensuring sustainable, high-quality patient care.

Masagos added that these initiatives are aligned with Singapore’s broader objectives to strengthen its healthcare system. This investment aims to position AHPs as key players to the country’s holistic healthcare delivery.

Follow the link for more news on

Ministry of Health

Also Read

Global REM sleep behaviour disorder market to reach $438.6m by 2028

Bladder cancer cases to hit 340,000 by 2033

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit

Top News

Global REM sleep behaviour disorder market to reach $438.6m by 2028

It is driven the increasing integration of AI and ML in RBD detection.

Healthcare

47 minutes ago

SG to launch national strategy for allied health professionals

It will also implement a mandatory continuing professional education by 2026.

Healthcare

19 hours ago

Bladder cancer cases to hit 340,000 by 2033

Older adults aged 60 and above make up about 87% of diagnosed cases.Bladder cancer cases in eight major markets, including Japan and China, are projected to grow at an annual rate of 2.24%, rising from 280,0000 cases in 2023 to 340,000 in 2033, according to GlobalData. The US will have the highest number of diagnosed cases at approximately 100,000, whilst France will report the lowest at 20,000 for 2023.Antara Bhattacharya, an associate project manager in GlobalData’s Epidemiology team, noted that men are more affected, comprising about 78% of cases, compared to 22% for women. Older adults aged 60 and above make up nearly 87% of diagnosed cases, with younger adults aged 18 to 59 accounting for about 13%.Roughly 45% of bladder cancer cases were diagnosed in early stages, with severe cases making up only 6%. Furthermore, about 79% of cases were detected at early tumour stages, compared to 4% in more advanced stages. Bhattacharya attributed the high diagnosis rates to the increased use of cystoscopy, an invasive diagnostic procedure. However, even with early-stage diagnosis, relapse and recurrence remain common, affecting approximately 74% of cases.Bladder cancer, the ninth most common type of cancer, poses challenges due to the cost and complexity of timely detection. Bhattacharya emphasised the need for comprehensive research and improved medical strategies to enhance early detection and treatment. Ongoing epidemiological studies focusing on stages of bladder cancer with a high likelihood of recurrence can contribute to better treatment outcomes. Effective treatment of bladder cancer involves a multi-pronged approach, combining medical and surgical care, lifestyle adjustments, continuous support, as well as advanced treatments like immunotherapy, targeted therapy, participation in clinical trials, and consistent follow-up.

Healthcare

23 hours ago

Primary open-angle glaucoma cases to grow to 10 million by 2033